Literature DB >> 12114533

Modulating influence on HIV/AIDS by interacting RANTES gene variants.

Ping An1, George W Nelson, Lihua Wang, Sharyne Donfield, James J Goedert, John Phair, David Vlahov, Susan Buchbinder, William L Farrar, William Modi, Stephen J O'Brien, Cheryl A Winkler.   

Abstract

RANTES (regulated on activation normal T cell expressed and secreted), a ligand for the CC chemokine receptor 5, potently inhibits HIV-1 replication in vitro. We tested the influence of four RANTES single nucleotide polymorphism (SNP) variants and their haplotypes on HIV-1 infection and AIDS progression in five AIDS cohorts. Three SNPs in the RANTES gene region on chromosome 17 (403A in the promoter, In1.1C in the first intron, and 3'222C in the 3' untranslated region) are associated with increased frequency of HIV-1 infection. The common In1.1C SNP allele is nested within an intronic regulatory sequence element that exhibits differential allele binding to nuclear proteins and a down-regulation of gene transcription. The In1.1C allele or haplotypes that include In1.1C display a strong dominant association with rapid progression to AIDS among HIV-1-infected individuals in African-American, European-American, and combined cohorts. The principal RANTES SNP genetic influence on AIDS progression derives from the down-regulating RANTES In1.1C allele, although linkage disequilibrium with adjoining RANTES SNPs including a weaker up-regulating RANTES promoter allele (-28G), can modify the observed epidemiological patterns. The In1.1C-bearing genotypes account for 37% of the attributable risk for rapid progression among African Americans and may also be an important influence on AIDS progression in Africa. The diminished transcription of RANTES afforded by the In1.1C regulatory allele is consistent with increased HIV-1 spread in vivo, leading to accelerated progression to AIDS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12114533      PMCID: PMC126614          DOI: 10.1073/pnas.142313799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Authors:  M W Smith; M Dean; M Carrington; C Winkler; G A Huttley; D A Lomb; J J Goedert; T R O'Brien; L P Jacobson; R Kaslow; S Buchbinder; E Vittinghoff; D Vlahov; K Hoots; M W Hilgartner; S J O'Brien
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

2.  NIRCA: a rapid robust method for screening for unknown point mutations.

Authors:  M M Goldrick; G R Kimball; Q Liu; L A Martin; S S Sommer; J Y Tseng
Journal:  Biotechniques       Date:  1996-07       Impact factor: 1.993

3.  Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients.

Authors:  S Zanussi; M D'Andrea; C Simonelli; U Tirelli; P De Paoli
Journal:  AIDS       Date:  1996-10       Impact factor: 4.177

4.  An E-M algorithm and testing strategy for multiple-locus haplotypes.

Authors:  J C Long; R C Williams; M Urbanek
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

5.  Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

Authors:  G Simmons; P R Clapham; L Picard; R E Offord; M M Rosenkilde; T W Schwartz; R Buser; T N Wells; A E Proudfoot
Journal:  Science       Date:  1997-04-11       Impact factor: 47.728

6.  Chemokine-independent in vitro resistance to human immunodeficiency virus (HIV-1) correlating with low viremia in long-term and recently infected HIV-1-positive persons.

Authors:  D H Schwartz; R C Castillo; S Arango-Jaramillo; U K Sharma; H F Song; G Sridharan
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

7.  Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.

Authors:  A Trkola; W A Paxton; S P Monard; J A Hoxie; M A Siani; D A Thompson; L Wu; C R Mackay; R Horuk; J P Moore
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure.

Authors:  W A Paxton; S R Martin; D Tse; T R O'Brien; J Skurnick; N L VanDevanter; N Padian; J F Braun; D P Kotler; S M Wolinsky; R A Koup
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

9.  Long-term HIV-1 infection without immunologic progression.

Authors:  S P Buchbinder; M H Katz; N A Hessol; P M O'Malley; S D Holmberg
Journal:  AIDS       Date:  1994-08       Impact factor: 4.177

10.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

View more
  51 in total

1.  Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS.

Authors:  Efe Sezgin; Sher L Hendrickson; Douglas A Jabs; Mark L Van Natta; Richard A Lewis; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

Review 2.  Host genetic factors in susceptibility to HIV-1 infection and progression to AIDS.

Authors:  Koushik Chatterjee
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

Review 3.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

4.  Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.

Authors:  Marie-Luise Berres; Rory R Koenen; Anna Rueland; Mirko Moreno Zaldivar; Daniel Heinrichs; Hacer Sahin; Petra Schmitz; Konrad L Streetz; Thomas Berg; Nikolaus Gassler; Ralf Weiskirchen; Amanda Proudfoot; Christian Weber; Christian Trautwein; Hermann E Wasmuth
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

5.  Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional study.

Authors:  Golo Ahlenstiel; Agathe Iwan; Jacob Nattermann; Karin Bueren; Jurgen K Rockstroh; Hans H Brackmann; Bernd Kupfer; Olfert Landt; Amnon Peled; Tilman Sauerbruch; Ulrich Spengler; Rainer P Woitas
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

6.  The RANTES -28 g polymorphism is associated with primary sclerosing cholangitis.

Authors:  Liesbet Henckaerts; Johan Fevery; Werner Van Steenbergen; Chris Verslype; Frederik Nevens; Paul Yap; Tania Roskams; Paul Rutgeerts; Severine Vermeire
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

7.  Sex-specific association of RANTES gene -403 variant in Meniere's disease.

Authors:  Nasrin Yazdani; Marzieh Mojbafan; Motahareh Taleba; Parvin Amiri; Farzaneh Nejadian; Mohammadtaghi Khorsandi Ashtiani; Mahsa M Amoli
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-25       Impact factor: 2.503

8.  Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression.

Authors:  Gabriela Bleiber; Margaret May; Raquel Martinez; Pascal Meylan; Jürg Ott; Jacques S Beckmann; Amalio Telenti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  On the general theory of the origins of retroviruses.

Authors:  Misaki Wayengera
Journal:  Theor Biol Med Model       Date:  2010-02-16       Impact factor: 2.432

10.  Polymorphisms of RANTES and IL-4 genes in cerebral infarction.

Authors:  Jae-Young Um; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2008-08-12       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.